Clinical Trial Update: Sublingual Immunotherapy in Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sublingual immunotherapy in patients with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: Zhejiang University | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED